ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Sole Source Negotiations

March 7, 1975

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986

Public Health Service: Scientific Papers Become “Deliverables” In Own RFP

October 3, 1997

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

Fisher Says Forget Grants-Contract Argument; What’s Needed Is More Flexibility

April 13, 1979

Majority Of U.S. Cancer Patients Receive High-Quality Care, ASCO Study Finds

July 29, 2005